# the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia

> **NCT02602977** · EARLY_PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Autoimmune Diseases
- Infection

## Interventions

- **OTHER:** Multiple-dose Remote Ischemic Preconditioning
- **OTHER:** Single-dose Remote Ischemic Preconditioning
- **BIOLOGICAL:** LPS infusion

## Key facts

- **NCT ID:** NCT02602977
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602977, "the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02602977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*